ERELZI

This brand name is authorized in Albania, Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug ERELZI contains one active pharmaceutical ingredient (API):

1 Etanercept UNII OP401G7OJC - ETANERCEPT

Etanercept is a competitive inhibitor of TNF binding to its cell surface receptors, and thereby inhibits the biological activity of TNF. The mechanism of action of etanercept is thought to be its competitive inhibition of TNF binding to cell surface TNFR, preventing TNF-mediated cellular responses by rendering TNF biologically inactive. Read about Etanercept

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AB01	Etanercept	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 663/237, 663/237a
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 511520100072407, 511520100072507
Country: CA	Health Products and Food Branch	Identifier(s): 02462850, 02462869, 02462877
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 11089204, 11594304, 11594310, 11594327, 11594333, 11594356, 11594362, 11594379, 12671840, 13600256, 13696121, 13781223, 13781252, 13913050, 13913067, 13913073, 13913096, 14035605, 14035611, 14131906, 14131935, 14131941, 14131958, 14137369, 14137375, 14137381, 14137398, 14163786, 14163792, 14163800, 14163817, 14212266, 14212272, 14254388, 14274037, 15193542, 15200147, 15200153, 15200176, 15200182, 15746998, 15747012, 15997447, 15997453, 16036997, 16037005, 16037011, 16037028, 16702276, 16702282, 16798715, 16798721, 16798738, 16798744, 16798750, 16958024, 16958030, 17166897, 17166905, 17166934, 17166940, 17304709, 17304715, 17312465, 17396083, 17396108, 17848415, 17848421
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 231-MBE-0322, 241-MBE-1222
Country: EE	Ravimiamet	Identifier(s): 1748460, 1748471, 1748482, 1748493, 1748505, 1748516, 1748527, 1748538, 1748549, 1748550, 1748561, 1748572, 1777495, 1777507
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171195003, 1171195007, 1171195010
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 096150, 149166, 453029, 585085, 598281
Country: FR	Base de données publique des médicaments	Identifier(s): 61382671, 64784134, 67270711
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 346338, 346340, 346342
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8654, 8655, 8656
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083188, 1083189, 1083190, 1083191, 1083192, 1083193, 1083194, 1083195, 1083196, 1083197, 1083198, 1083199, 1084550, 1084551
Country: NL	Z-Index G-Standaard	Identifier(s): 15208826, 15208850
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106321, 81647, 81655
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 19579, 19594, 19595
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100391517, 100391523, 100391530
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63831001, W63832001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681428951178, 8681428951185, 8681428951192, 8681428951208, 8681428951215, 8681428951222, 8681428951413, 8681428951420, 8681428951437
Country: ZA	Health Products Regulatory Authority	Identifier(s): 55/3.1/0392, 55/3.1/0393